Navigation Links
TVM Capital MENA Marks Inauguration of ProVita International Medical Center
Date:10/12/2011

DUBAI, UAE, October 12, 2011 /PRNewswire/ --

TVM Capital MENA has today inaugurated its first investment in the MENA region.

The official opening of ProVita International Medical Center in Abu Dhabi was attended by TVM Capital MENA Chairman & CEO Dr. Helmut M. Schuehsler who also serves as Chairman of the Board at ProVita. The region's first long-term care facility for acute, ventilator dependent patients in a non-hospital setting, ProVita addresses a significant market need in the region. The facility offers round the clock care for acute ventilator dependent patients outside of the Intensive Care Unit (ICU) where they usually have to live, if no such facilities as ProVita exist.

The genesis of the clinic, and more specifically the collaboration with the founder of ProVita clinics in Germany, Christina Shawky-Boehme, is consistent with the TVM Capital MENA strategy of involving leading operators from more fully developed healthcare markets such as in Europe or North America to provide unique and specialized healthcare services in the Middle East, directly catering to the growing local demand. The investment in ProVita was originally announced in November 2010 and the facility was eventually opened in February 2011. The company hopes to meet enough demand in other countries to be able to open additional long-term care facilities in the region, including the Kingdom of Saudi Arabia.

According to Dr. Helmut M. Schuehsler, Chairman & CEO of TVM Capital MENA, '' We are proud of the work that ProVita has been able to do and the difference it has made to the quality of life of severely ill and ventilator dependent patients in Abu Dhabi. The facility is a first for the region and a testament to the growth and development of the local healthcare industry. The demand for long-term care remains high and we hope to expand the ProVita offering throughout the region.'’

TVM Capital MENA is the first international private equity house with a focus in healthcare to establish operations in the MENA region. The three founding investors of the TVM Capital MENA Healthcare Private Equity Fund are the IFC (International Financing Corporation), GE Healthcare and The Olayan Group.

The second TVM Capital MENA investment in the region, Bourn Hall International, had a soft opening of its first in-vitro-fertilization (IVF) clinic in Kochi, Kerala, India in July 2011 and is currently building out additional facilities in Delhi and Dubai. The founders of BHI invented IVF in 1978 with the first successful birth of a child conceived through an IVF procedure. As the ultimate testament of Bourn Hall's world-leading expertise in the field of fertility, its founder, Dr. Bob Edwards, was awarded in 2010 the Nobel Prize in medicine for the invention of IVF.

Notes to editor

TVM Capital MENA Ltd. is a private equity firm focusing on investments in health care in the Middle East and North Africa (MENA).  TVM Capital MENA operates out of the Dubai International Financial Center and is licensed and regulated by the DFSA.  The team of TVM Capital MENA is affiliated to the international Life Science Practice of TVM Capital. The TVM Capital Life Science Practice currently manages €820 million from more than 50 investors. The investment professionals draw upon the experience, international approach and demonstrated success of about 80 exits from almost 120 investments. Exits include nearly 40 initial public offerings on the NASDAQ, and the London, Frankfurt, Zurich and Vienna Stock Exchanges and 25 trade sales and mergers. TVM Capital Life Science operates with an integrated team from its headquarters in Munich and a representative office in Boston. The team combines long-standing international investment experience and operating track records with extensive networks in and knowledge of the MENA region.

More information please visit: http://www.tvm-capital.ae


'/>"/>
SOURCE TVM Capital MENA
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
2. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
3. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
6. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
7. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
8. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
9. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
10. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
Breaking Biology News(10 mins):